EP Patent

EP2827853A1 — Compositions and methods for oral delivery of encapsulated diethylenetriaminepentaacetate particles

Assigned to Ology Bioservices Inc · Expires 2015-01-28 · 11y expired

What this patent protects

The present disclosure is directed to compositions comprising encapsulated particles of diethylenetriaminepentaacetate (DTPA) and a zinc salt such as zinc acetate, and to pharmaceutical compositions comprising such encapsulated compositions. The present disclosure is also directe…

USPTO Abstract

The present disclosure is directed to compositions comprising encapsulated particles of diethylenetriaminepentaacetate (DTPA) and a zinc salt such as zinc acetate, and to pharmaceutical compositions comprising such encapsulated compositions. The present disclosure is also directed to methods of treatment by administering an effective amount of the compositions and pharmaceutical compositions of the present disclosure, to methods of making such encapsulated particle compositions, and to methods of making the corresponding pharmaceutical compositions.

Drugs covered by this patent

Patent Metadata

Patent number
EP2827853A1
Jurisdiction
EP
Classification
Expires
2015-01-28
Drug substance claim
No
Drug product claim
No
Assignee
Ology Bioservices Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.